Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 8 , Pages 841-849 , August 2010

COMT Val158Met Genotype as a Risk Factor for Problem Behaviors in Youth

  • Matthew D. Albaugh, B.A.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • Valerie S. Harder, M.H.S., Ph.D.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • Robert R. Althoff, M.D., Ph.D.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • David C. Rettew, M.D.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • Erik A. Ehli, R.N., M.S.

      Affiliations

    • Avera Institute for Human Behavioral Genetics, Amsterdam, the Netherlands
    • ,
  • Timea Lengyel-Nelson, M.S.

      Affiliations

    • Avera Institute for Human Behavioral Genetics, Amsterdam, the Netherlands
    • ,
  • Gareth E. Davies, Ph.D.

      Affiliations

    • Avera Institute for Human Behavioral Genetics, Amsterdam, the Netherlands
    • ,
  • Lynsay Ayer, Ph.D.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • Julie Sulman, B.A.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine
    • ,
  • Catherine Stanger, Ph.D.

      Affiliations

    • Center for Addiction Research at University of Arkansas for Medical Sciences, Amsterdam, the Netherlands
    • ,
  • James J. Hudziak, M.D.

      Affiliations

    • Vermont Center for Children, Youth, and Families at the University of Vermont, College of Medicine, Vrije Universiteit, Amsterdam, the Netherlands, and ErasmusMC, Rotterdam, the Netherlands
    • Corresponding Author InformationCorrespondence to Dr. James J. Hudziak, The Vermont Center for Children, Youth and Families, University of Vermont College of Medicine, University Health Center campus, 1 South Prospect Street, Burlington, VT 05401

,Accepted 27 May 2010.

References 

  1. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243-2450
  2. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75:807–821
  3. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–4210
  4. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol. 1999;39:19–52
  5. Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization. J Comp Neurol. 2001;432:119–136
  6. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci. 2004;24:5331–5335
  7. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A. 1998;95:9991–9996
  8. Senault B. Intraspecific aggressive behavior induced by apomorphine in the rat ([In French]). Psychopharmacologia. 1970;18:271–287
  9. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet. 1999;88:628–633
  10. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry. 1998;155:835–837
  11. Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry. 2002;159:23–29
  12. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry. 2003;54:34–39
  13. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: Evidence for association with aggressive and antisocial behavior. Psychiatry Res. 1997;69:71–77
  14. Caspi A, Langley K, Milne B, Moffitt TE, O'Donovan M, Owen MJ, et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2008;65:203–210
  15. Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV. Genetic risk for conduct disorder symptom subtypes in an ADHD sample: Specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry. 2009;48:757–764
  16. Holmboe K, Nemoda Z, Fearon RM, Csibra G, Sasvari-Szekely M, Johnson MH. Polymorphisms in dopamine system genes are associated with individual differences in attention in infancy. Dev Psychol. 2010;46:404–416
  17. Sengupta S, Grizenko N, Schmitz N, Schwartz G, Bellingham J, Polotskaia A, et al. COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD. Neuropsychopharmacology. 2008;33:3069–3077
  18. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet. 1999;88:497–502
  19. Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1431–1435
  20. DeYoung CG, Getchell M, Koposov RA, Yrigollen CM, Haeffel GJ, af Klinteberg B, et al. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr Genet. 2010;20:20–24
  21. Palmason H, Moser D, Sigmund J, Vogler C, Hanig S, et al. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. J Neural Transm. 2010;117:259–267
  22. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience. 1991;41:1–24
  23. Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004;29:1943–1961
  24. Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff HB, Arnold LE, et al. Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol. 2000;28:555–568
  25. Wells KC, Epstein JN, Hinshaw SP, Conners CK, Klaric J, Abikoff HB, et al. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): An empirical analysis in the MTA study. J Abnorm Child Psychol. 2000;28:543–553
  26. The Conduct Problems Prevention Research Group. Evaluation of the first 3 years of the Fast Track prevention trial with children at high risk for adolescent conduct problems. J Abnorm Child Psychol. 2002;30:19–35
  27. Voelker P, Sheese BE, Rothbart MK, Posner MI. Variations in catechol-O-methyltransferase gene interact with parenting to influence attention in early development. Neuroscience. 2009;164:121–130
  28. Crick NR, Grotpeter JK. Relational aggression, gender, and social-psychological adjustment. Child Dev. 1995;66:710–722
  29. Hudziak JJ, Copeland W, Rudiger LP, Achenbach TM, Heath AC, Todd RD. Genetic influences on childhood competencies: A twin study. J Am Acad Child Adolesc Psychiatry. 2003;42:357–363
  30. Achenbach TM. Manual for the Child Behavior Checklist 4–18 and 1991 profile. Burlington VT: University of Vermont, Department of Psychiatry; 1991;
  31. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms & profiles. Burlington VT: University of Vermont, Research Center for Children,Youth, and Families; 2001;
  32. Ligthart L, Bartels M, Hoekstra RA, Hudziak JJ, Boomsma DI. Genetic contributions to subtypes of aggression. Twin Res Hum Genet. 2005;8:483–491
  33. Frick PJ. The Alabama Parenting Questionnaire. Birmingham, AL: University of Alabama; 1991;
  34. Bartels M, van Beijsterveldt CE, Derks EM, Stroet TM, Polderman TJ, Hudziak JJ, et al. Young Netherlands Twin Register (Y-NTR): A longitudinal multiple informant study of problem behavior. Twin Res Hum Genet. 2007;10:3–11
  35. Hollingshead AB. Four-factor Index of Social Status. New Haven, CT: Yale University; 1975;
  36. Ehli EA, Lengyel-Nelson T, Hudziak JJ, Davies GE. Using a commercially available DNA extraction kit to obtain high quality human genomic DNA suitable for PCR and genotyping from 11-year-old saliva saturated cotton spit wads. BMC Res Notes. 2008;1:133
  37. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652–654
  38. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, et al. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry. 2006;63:1396–1406
  39. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, et al. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci. 2005;25:836–842
  40. Smolka MN, Buhler M, Schumann G, Klein S, Hu XZ, Moayer M, et al. Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry. 2007;12:307–317
  41. Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH, Gordon E, et al. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias [published online ahead of print February 6, 2010]. Neuroimage. 2010;
  42. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation–a possible prelude to violence. Science. 2000;289:591–594
  43. Mehio-Sibai A, Feinleib M, Sibai TA, Armenian HK. A positive or a negative confounding variable? (A simple teaching aid for clinicians and students). Ann Epidemiol. 2005;15:421–423

 This article is discussed in an editorial by Drs. James J. Hudziak and Stephen V. Faraone on page 729.

 This article was reviewed under and accepted by Ad Hoc Editor James F. Leckman, M.D.

 The corresponding author gratefully acknowledges support from the National Institutes of Health (Grant MH01265).

 This is one of several articles published in the August and September issues of the Journal of the American Academy of Child and Adolescent Psychiatry that explores the intersection of genetics and mental health disorders in children and adolescents. The editors invite the reader to investigate the additional articles on this burgeoning area of developmental psychopathology.

 Disclosure: Drs. Harder, Althoff, Rettew, Davies, Stanger, and Hudziak, and Mr. Albaugh, Mr. Ehli, Ms. Lengyel-Nelson, Ms. Ayer, and Ms. Sulman report no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00425-9

doi: 10.1016/j.jaac.2010.05.015

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 8 , Pages 841-849 , August 2010

Article Tools